Skip to main content
Neil Bander, MD, Urology, New York, NY

NeilHarrisonBanderMD

Urology • New York, NY

Surgical Oncology

Professor, Urology, Weill Cornell Medical College

Join to view full profile

Dr. Bander is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bander's full profile

Already have an account?

  • Office

    525 E 68th St
    # F-900
    New York, NY 10065
    Phone+1 212-746-5493
    Fax+1 212-746-8941

Education & Training

  • University of Connecticut
    University of ConnecticutResidency, Urology, 1978 - 1980
  • University of Connecticut School of Medicine
    University of Connecticut School of MedicineInternship, Transitional Year, 1977 - 1978
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Surgery, 1977 - 1977
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Surgery, 1974 - 1976
  • Uconn School Of Medicine
    Uconn School Of MedicineClass of 1974

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1976 - 2022
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • AACR: Philip Kantoff Discusses Convergent's Unique Path to Treating Prostate Cancer
    AACR: Philip Kantoff Discusses Convergent's Unique Path to Treating Prostate CancerApril 14th, 2022
  • Clinical Trial Equity in Radionuclide Treatment for Prostate Cancer - Joseph Osborne
    Clinical Trial Equity in Radionuclide Treatment for Prostate Cancer - Joseph OsborneApril 7th, 2022
  • AIkido Pharma Has Pending Data Results on June 4th, with Strongest Balance Sheet in Its History While Trading Below Cash
    AIkido Pharma Has Pending Data Results on June 4th, with Strongest Balance Sheet in Its History While Trading Below CashMay 20th, 2021
  • Join now to see all

Grant Support

  • PH. I Humanized MAB Huj591-Dota-177lu/ Relapsed Prostate CancerNational Center For Research Resources2004
  • Monoclonal Antibody Muj591 Patients W/ Hormone Independant Prostate CancerNational Center For Research Resources1999–2001
  • Phase I/Ii/ 131 Iodine MAB Prost 30/Patients W/Advanced Prostate CancerNational Center For Research Resources1998–2000
  • Phase 1 Trial Of Monoclonal Antibody F31 In Renal CancerNational Center For Research Resources1997–2000

Professional Memberships

Dr. Neil Bander, Dr. Neil Bander, MD, Dr. N Bander, Dr. Neil Harrison Bander